Revolution Medicines, Inc. (RVMD) Misses Q2 EPS by 19c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($1.31), $0.19 worse than the analyst estimate of ($1.12).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
• JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight